12 research outputs found

    Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis

    No full text
    <div><p>The fungus <i>Cryptococcus</i> is a major cause of meningoencephalitis in HIV-infected as well as HIV-uninfected individuals with mortalities in developed countries of 20% and 30%, respectively. In HIV-related disease, defects in T-cell immunity are paramount, whereas there is little understanding of mechanisms of susceptibility in non-HIV related disease, especially that occurring in previously healthy adults. The present description is the first detailed immunological study of non-HIV-infected patients including those with severe central nervous system (s-CNS) disease to 1) identify mechanisms of susceptibility as well as 2) understand mechanisms underlying severe disease. Despite the expectation that, as in HIV, T-cell immunity would be deficient in such patients, cerebrospinal fluid (CSF) immunophenotyping, T-cell activation studies, soluble cytokine mapping and tissue cellular phenotyping demonstrated that patients with s-CNS disease had effective microbiological control, but displayed strong intrathecal expansion and activation of cells of both the innate and adaptive immunity including HLA-DR+ CD4+ and CD8+ cells and NK cells. These expanded CSF T cells were enriched for cryptococcal-antigen specific CD4+ cells and expressed high levels of IFN-γ as well as a lack of elevated CSF levels of typical T-cell specific Th2 cytokines -- IL-4 and IL-13. This inflammatory response was accompanied by elevated levels of CSF NFL, a marker of axonal damage, consistent with ongoing neurological damage. However, while tissue macrophage recruitment to the site of infection was intact, polarization studies of brain biopsy and autopsy specimens demonstrated an M2 macrophage polarization and poor phagocytosis of fungal cells. These studies thus expand the paradigm for cryptococcal disease susceptibility to include a prominent role for macrophage activation defects and suggest a spectrum of disease whereby severe neurological disease is characterized by immune-mediated host cell damage.</p></div

    <i>Ex vivo</i> cryptococcal antigenic stimulation by pulsed autologous mature dendritic cells (mDCs) co-cultured with T lymphocytes from CSF or blood demonstrates compartmentalization of immune responses in a subgroup of 8 s-CNS and 5 non-CNS patients.

    No full text
    <p>(A) Sum of cytokine-producing IFN-γ+, TNF-α+, and IFN-γ+/TNF-α+ CD4+ and CD8+ T lymphocytes (after mDC presentation of MP and Crypto). Events are normalized to fluorescent beads. B) IFN-γ production of activated CD4+ and CD8+ T lymphocytes after Crypto presentation by mDCs. Tc = T lymphocyte; Crypto = glass bead-fractured, heat-killed <i>C</i>. <i>neoformans</i> strain H99; MP = <i>C</i>. <i>neoformans</i> mannoprotein; No Ag = no antigen (un-loaded mDCs). Open circles and bars are representative of non-CNS (Pulmonary) cases, filled circles and bars of s-CNS (CNS) cases. Error bars specify minimum to maximum values. *0.01≤p<0.05; **0.001≤p<0.01; ***0.0001≤p<0.001.</p

    Immunophenotyping demonstrates increased absolute counts of CSF circulating activated HLA-DR+ CD4+ and CD8+ as well as—B-cells in s-CNS patients.

    No full text
    <p>Absolute numbers and proportions of activated CD4+ and CD8+ T lymphocytes (HLA-DR+),—and B lymphocytes were assessed in fresh CSF or blood by flow cytometry as described in Materials and Methods in patients with s-CNS disease (N = 17), non-CNS disease (N = 6), and healthy donors (HD; N = 11). Proportions are calculated from the total CD45+ cells. *0.01≤p<0.05; **0.001≤p<0.01; ***0.0001≤p<0.001.</p

    Intrathecal cytokine and chemokine profiles reveal elevated IFN-γ and related inflammatory responses in cryptococcosis patients with s-CNS disease compared with non-CNS disease and healthy donors (HD).

    No full text
    <p>CSF was analyzed using Luminex assays according to the Materials and Methods section. (a) IFN-γ, (b) CXCL10 (IP-10), (c) IL-18, (d) TNF-α, (e) IL-10, (f) IL-4, (g) IL-6, (h) IL-13, (i) MCP-1/CCL2, (j) MIP-1α/CCL3, (k) MCP-3/CCL7, and (l) MIP-3β/CCL19. Cytokine and chemokine concentrations were expressed as log<sub>10</sub> picogram per milliliter (pg/ml) in s-CNS and non-CNS patients and HD. IL-8, GM-CSF, M-CSF, IL-12p40, IL-17, and IFN-α2 are not shown (without statistically significant differences among case groups). Error bars represent minimum to maximum values. *0.01≤p<0.05; **0.001≤p<0.01; ***0.0001≤p<0.001; ****p<0.0001.</p

    Brain biopsy specimens from patients with s-CNS cryptococcosis demonstrate macrophage and T-cell tissue infiltration.

    No full text
    <p>A) Diagnostic specimens obtained from two s-CNS patients were stained with macrophage markers CD 68 and CD163 and T-cell marker CD3. B) Immunofluorescence of brain biopsy of one patient after staining with macrophage marker CD68 and M1 marker (iNOS) and M2 marker (CD200R1), fungal stain, calcofluor white (CFW) and nuclear stain, 4',6-diamidino-2-phenylindole (DAPI). Magnification at 10 x with inset at 20x and scale bar set at 100 μm for 10x images.</p

    Autopsy report summary of patients who died of severe CNS (s-CNS) cryptococcosis.

    No full text
    <p>Cryptococcus autopsy cases for brain immunhistochemistry that have been collated according to the following inclusion criteria based on findings 1 week prior to death: (1.) cryptococcal meningoencephalitis with or without dissemination (CSF India ink OR culture positive), (2.) Glasgow coma score < 8 for > 48 hours, (3.) presence of Babinski or other upper motor neuron signs OR seizure activity, and (4.) exclusion of competing risks.</p><p>PMN = polymorphonuclear leukocytes</p><p>*PCR of our paraffin embedded brain autopsy specimens revealed <i>C</i>. <i>neoformans</i> in all 5 autopsy specimens.</p><p>**tapered off by time of death</p><p><sup>1</sup> in remission</p><p>Autopsy report summary of patients who died of severe CNS (s-CNS) cryptococcosis.</p
    corecore